A2M and focal segmental glomerulosclerosis: • Molecular endothelial signatures suggested 2 distinct FSGS patient subgroups with α-2 macroglobulin (A2M) as a key downstream mediator of the endothelial cell phenotype and was shown to have prognostic significance